SCHEMBL5326902

SCHEMBL5326902

NS(=O)(=O)NCCCCCC(=O)Nc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 19/20 1.00
ALDH1A1 P00352 1/20 0.64
LMNA P02545 1/20 0.64
HDAC4 P56524 14/20 0.60
HDAC1 Q13547 14/20 0.60
HDAC7 Q8WUI4 14/20 0.60
HDAC11 Q96DB2 14/20 0.60
HDAC8 Q9BY41 14/20 0.60
HDAC9 Q9UKV0 14/20 0.60
HDAC5 Q9UQL6 14/20 0.60
HDAC3 O15379 13/20 0.60
HDAC2 Q92769 13/20 0.60
HDAC10 Q969S8 13/20 0.60
NCOR2 Q9Y618 2/20 0.60
KDM4E B2RXH2 1/20 0.60
BRD4 O60885 1/20 0.60
NCOR1 O75376 1/20 0.60
NR1I2 O75469 1/20 0.60
EGFR P00533 1/20 0.60
CYP3A4 P08684 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8114106 0.89 HDAC6 (0.79) HDAC6ALDH1A1LMNAHDAC4HDAC1
SCHEMBL5327672 0.88 HDAC6 (1.00) HDAC6ALDH1A1LMNAHDAC4HDAC1
SCHEMBL4831701 0.85 HDAC6 (0.74) HDAC6ALDH1A1LMNAHDAC4HDAC1
Hydroxyamine SCHEMBL1268824 0.82 HDAC6 (0.79) HDAC6HDAC4HDAC1HDAC7HDAC11
SCHEMBL6665592 0.82 HDAC4 (0.85) HDAC6HDAC4HDAC1HDAC7HDAC11
SCHEMBL6669511 0.82 HDAC4 (0.85) HDAC6HDAC4HDAC1HDAC7HDAC11
SCHEMBL137348 0.82 HDAC4 (0.85) HDAC6HDAC4HDAC1HDAC7HDAC11
SCHEMBL1065393 0.82 HDAC4 (0.85) HDAC6HDAC4HDAC1HDAC7HDAC11
SCHEMBL1833186 0.82 HDAC6 (0.69) HDAC6HDAC4HDAC1HDAC7HDAC11
SCHEMBL14254926 0.82 HDAC6 (0.69) HDAC6HDAC4HDAC1HDAC7HDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007143822-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-21 WO disclosed
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HAT1 HDAC6 11/4885ALDH1A1 854/4885LMNA 2203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.